(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
B-The scoring system used in chronic phase
I-The current 5-year overall survival rate of CML
G-When to give H2RAs with dasatinib
N-Drug class that revolutionized CML treatment
I-TKIs are major substrates for this liver enzyme
B-Patients have presence of this BCR-ABL protein indicative of CML
G-The landmark for the first TKI
N-Too many of these blood cells are abnormal in CML
G-60-70% of patients with CML present with this symptom
I-Treatment for blast phase CML
B-Percentage of blasts present in the blast phase
O-The number of distinct clinical phases in CML
O-Non-pharmacological treatment for CML
G-Moderate to high emetogenic risk TKIs
G-Translocation between these two chromosomes occur in CML
O-I failed 3 lines of TKIs, I can try this agent next
N-I have the T315I mutation but also have elevated lipase
O-Number of blasts present in accelerated phase
N-The recommended criteria used for accelerated phase
I-I avoid this drug class with bosutinib, nilotinib and dasatinib
B-Response when BCR-ABL1 (IS) is <0.01%
B-I want to avoid this TKI if I do not want diarrhea
O-This TKI has the most metabolic syndrome
I-After 3 months, I have 3% BCR-ABL, I have this TKI response